The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Bykov A.O.

Pirogov Russian National Research Medical University;
Moscow Multi-Field Clinical Center «Kommunarka»;
Research Institute of Healthcare Organization and Medical Management

Shifman E.M.

Pirogov Russian National Research Medical University;
Moscow Multi-Field Clinical Center «Kommunarka»

Protsenko D.N.

Pirogov National Research Medical University;
Moscow City Multi-field Clinical Center «Kommunarka»

Yakovlev S.V.

Sechenov First Moscow State Medical University

Belotserkovskiy B.Z.

Pirogov National Research Medical University;
Moscow City Multi-field Clinical Center «Kommunarka»

Ni O.G.

Moscow Multi-Field Clinical Center «Kommunarka»

Kruglov A.N.

Moscow Multi-Field Clinical Center «Kommunarka»

Bryleva A.A.

Moscow Multi-Field Clinical Center «Kommunarka»

Matyash M.I.

Moscow City Multi-field Clinical Center «Kommunarka»

Larin E.S.

Research Institute of Healthcare Organization and Medical Management

Risk factors of colonization and diversity of clinically significant carbapenemases in gut microbiota of ICU patients: a single-center prospective observational study

Authors:

Bykov A.O., Shifman E.M., Protsenko D.N., Yakovlev S.V., Belotserkovskiy B.Z., Ni O.G., Kruglov A.N., Bryleva A.A., Matyash M.I., Larin E.S.

More about the authors

Journal: Russian Journal of Anesthesiology and Reanimatology. 2024;(5): 41‑49

DOI: 10.17116/anaesthesiology202405141

Read: 1964 times

Download PDF (RU)
Download PDF
Contact the author
Table of contents

RISK FACTORS OF COLONIZATION AND DIVERSITY OF CLINICALLY SIGNIFICANT CARBAPENEMASES IN GUT MICROBIOTA OF ICU PATIENTS: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY
RISK FACTORS OF COLONIZATION AND DIVERSITY OF CLINICALLY SIGNIFICANT CARBAPENEMASES IN GUT MICROBIOTA OF ICU PATIENTS: A SINGLE-CENTER PROSPECTIVE OBSERVATIONAL STUDY

To cite this article:

Bykov AO, Shifman EM, Protsenko DN, et al. . Risk factors of colonization and diversity of clinically significant carbapenemases in gut microbiota of ICU patients: a single-center prospective observational study. Russian Journal of Anesthesiology and Reanimatology. 2024;(5):41‑49. (In Russ., In Engl.)
https://doi.org/10.17116/anaesthesiology202405141

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

BACKGROUND

Carbapenem-resistant Enterobacteriaceae have a major impact on ICU-stay and treatment outcomes.

OBJECTIVE

To identify the risk factors of colonization by CPE (carbapenemase-producing Enterobacterales) in ICU patients.

MATERIAL AND METHODS

We enrolled 94 ICU patients between November 2020 and January 2021 and divided then into 3 groups: group 1 (n=63) — all patients not colonized by CPE, group 2 (n=31) — colonized upon admission, group 3 (n=31) — colonized after 5-day ICU-stay. All patients underwent microbiological and molecular genetic testing via real-time PCR (AmpliSens MDR MBL-FL and AmpliSens MDR KPC/OXA-48-FL reagent kits) of rectal smear samples.

RESULTS

We found CPEs in rectal smear samples that mainly released carbapenemases OXA-48, NDM, KPC and their combinations. Pre-hospital risk factors for intestinal colonization by CPE were identified: male gender (OR=0.28, CI 95% [0.11, 0.74], p=0.010), hospital-stay within previous 3 months (OR=4.22, CI 95 % [1.38; 12.9], p=0.011) and previous antimicrobial therapy (OR=2.23, CI 95% [0.76; 6.54], p=0.145). There were the following risk factors after 5-day hospital-stay: primary colonization (OR=15.64, CI 95% [4.64; 52.73], p<0.0001), female gender (OR=2.51, CI 95% [0.96, 6.56], p<0.059), age (OR=0.969, CI 95% [0.931; 1.007], p=0.112), use of vasopressors (OR=27.11, CI 95% [2.43; 302.11], p=0.007), CRP (OR=0.997, CI 95% [0.992; 1.001], p=0.162), central venous catheter (OR=3.56, CI 95% [1.36; 9.30], p=0.010), proton pump inhibitors (OR 0.38, CI 95% [0.13; 1.11], p=0.077).

CONCLUSION

Early detection of CPE and carbapenemases and their monitoring are necessary to improve the effectiveness of antimicrobial therapy in ICU patients.

Keywords:

enterobacteriaceae
carbapenemases
Escherichia coli
Klebsiella pneumoniae
Proteus mirabilis

Authors:

Bykov A.O.

Pirogov Russian National Research Medical University;
Moscow Multi-Field Clinical Center «Kommunarka»;
Research Institute of Healthcare Organization and Medical Management

Shifman E.M.

Pirogov Russian National Research Medical University;
Moscow Multi-Field Clinical Center «Kommunarka»

Protsenko D.N.

Pirogov National Research Medical University;
Moscow City Multi-field Clinical Center «Kommunarka»

Yakovlev S.V.

Sechenov First Moscow State Medical University

Belotserkovskiy B.Z.

Pirogov National Research Medical University;
Moscow City Multi-field Clinical Center «Kommunarka»

Ni O.G.

Moscow Multi-Field Clinical Center «Kommunarka»

Kruglov A.N.

Moscow Multi-Field Clinical Center «Kommunarka»

Bryleva A.A.

Moscow Multi-Field Clinical Center «Kommunarka»

Matyash M.I.

Moscow City Multi-field Clinical Center «Kommunarka»

Larin E.S.

Research Institute of Healthcare Organization and Medical Management

Received:

22.03.2024

Accepted:

25.05.2024

Close metadata

References:

  1. Yi J, Kim K-H. Identification and infection control of carbapenem-resistant Enterobacterales in intensive care units. Acute and Critical Care. 2021;36(3):175-184.  https://doi.org/10.4266/acc.2021.00409
  2. The 2021 EUCAST breakpoint table (V. 11.0). Accessed July 20, 2024. https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_11.0_Breakpoint_Tables.pdf
  3. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399 (10325):629-655. Erratum in: Lancet. 2022;400(10358):1102. https://doi.org/10.1016/S0140-6736(21)02724-0
  4. Lutgring JD, Limbago BM. The problem of carbapenemase-producing-carbapenem-resistant-Enterobacteriaceae detection. Journal of Clinical Microbiology. 2016;54(3):529-534.  https://doi.org/10.1128/JCM.02771-15
  5. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. Multidrug-resistant, extensively drug resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection. 2012;18:268-281.  https://doi.org/10.1111/j.1469-0691.2011.03570.x
  6. McConville TH, Sullivan SB, Gomez-Simmonds A, Whittier S, Uhlemann AC. Carbapenem-resistant Enterobacteriaceae colonization (CRE) and subsequent risk of infection and 90-day mortality in critically ill patients, an observational study. PLoS One. 2017;12(10):e0186195. https://doi.org/10.1371/journal.pone.0186195
  7. Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, De Simone P, Biancofiore G, Boggi U, Barnini S, Menichetti F; Italian Group of Antimicrobial Stewardship (the GISA study group). Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study). Clinical Microbiology and Infection. 2022;28(2):298.e1-298.e7.  https://doi.org/10.1016/j.cmi.2021.06.031
  8. Zaha DC, Kiss R, Hegedűs C, Gesztelyi R, Bombicz M, Muresan M, Pallag A, Zrinyi M, Pall D, Vesa CM, Micle O. Recent advances in investigation, prevention, and management of healthcare-associated infections (HAIs): resistant multidrug strain colonization and its risk factors in an intensive care unit of a university hospital. BioMed Research International. 2019;2019:2510875. https://doi.org/10.1155/2019/2510875
  9. Yakovlev SV, Suvorova MP, Bykov AO. Infections Caused by Carbapenem-Resistant Enterobacterales: Epidemiology, Clinical Significance, and Possibilities for Antibiotic Therapy Optimization. Antibiotiki i khimioterapiya. 2020;65(5-6):41-69. (In Russ.). https://doi.org/10.37489/0235-2990-2020-65-5-6-41-69
  10. Lübbert C, Lippmann N, Busch T, Kaisers UX, Ducomble T, Eckmanns T, Rodloff AC. Long-term carriage of Klebsiella pneumoniae carbapenemase-2-producing K pneumoniae after a large single-center outbreak in Germany. American Journal of Infection Control. 2014;42(4):376-380.  https://doi.org/10.1016/j.ajic.2013.12.001
  11. Hansen GT. Continuous Evolution: Perspective on the Epidemiology of Carbapenemase Resistance among Enterobacterales and other Gram-Negative Bacteria. Infectious Diseases and Therapy. 2021;10(1):75-92.  https://doi.org/10.1007/s40121-020-00395-2
  12. Kuzmenkov AYu, Vinogradova AG, Trushin IV, Eidelshtein MV, Avramenko AA, Dekhnich AV, Kozlov RS. AMRmap: an interactive web platform for analysis of antimicrobial resistance surveillance data in Russia. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya. 2021;23(2):198-204. (In Russ.). https://doi.org/10.36488/cmac.2021.2.198-204
  13. Bykov AO, Suvorova MP, Protsenko DN, Yakovlev SV, Ignatenko OV, Burmistrova EN, Sychev IN, Krotenko NP. Analysis of the structure of bacteremia and sensitivity to antibiotics of microorganisms isolated in intensive care units in an emergency hospital in the period from 2003 to 2021: a retrospective observational study. Annals of Critical Care. 2023;2:55-65. (In Russ.). https://doi.org/10.21320/1818-474X-2023-2-55-65
  14. Belotserkovskiy BZ, Protsenko DN, Gelfand EB. Antimicrobial therapy of nosocomial pneumonia in era of growth of resistance to carbapenems. Russian Journal of Anesthesiology and Reanimatology. 2018;5:22-35. (In Russ.). https://doi.org/10.17116/anaesthesiology201805122
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.